Evidence map›Paper›PMID 10198068›Full record

ArticleMolecular biology of the cell1999

Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching.

H Joseph, A E Gorska, P Sohn, H L Moses, R Serra

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Building branched tissue structures: from single cell guidance to coordinated construction.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Review
  6. Article
  7. Review
  8. Article
  9. Targeting TGF-β signaling in cancer.Expert opinion on therapeutic targets · 2013
    Review
  10. Article
  11. Crosstalk between TGF-beta and MAPK signaling during corneal wound healing.Investigative ophthalmology & visual science · 2011
    Article
  12. Integrated morphodynamic signalling of the mammary gland.Nature reviews. Molecular cell biology · 2011
    Review
  13. Article
  14. Article
  15. Review
  16. Choreographing metastasis to the tune of LTBP.Journal of mammary gland biology and neoplasia · 2011
    Article
  17. The role of activin in mammary gland development and oncogenesis.Journal of mammary gland biology and neoplasia · 2011
    Review
  18. Wnt5a as an effector of TGFβ in mammary development and cancer.Journal of mammary gland biology and neoplasia · 2011
    Review
  19. Article
  20. TGF-beta biology in mammary development and breast cancer.Cold Spring Harbor perspectives in biology · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

H JosephDepartment of Cell Biology and The Vanderbilt Cancer Center, Vanderbilt University, Nashville, Tennessee 37232, USA.
A E Gorska
P Sohn
H L Moses
R Serra
Vanderbilt University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
TGF BETA SIGNALING IN CHONDROCYTE DIFFERENTIATIONR01AR045605 · NIAMS · VANDERBILT UNIVERSITY · PI SERRA, ROSA A. · 1998 to 2008
$1.5M
TRANSFORMING GROWTH FACTORS IN NEOPLASTIC TRANSFORMATIONR35CA042572 · NCI · VANDERBILT UNIVERSITY · PI MOSES, HAROLD L · 1986 to 1999
–
NCI NIH HHS CA-42572NCI NIH HHS CA-68485NCI NIH HHS P30 CA068485NIAMS NIH HHS R01 AR045605NIDDK NIH HHS DK-20593NIDDK NIH HHS P30 DK020593
6 · The paper itself

Abstract

Members of the transforming growth factor-beta (TGF-beta) superfamily signal through heteromeric type I and type II serine/threonine kinase receptors. Transgenic mice that overexpress a dominant-negative mutation of the TGF-beta type II receptor (DNIIR) under the control of a metallothionein-derived promoter (MT-DNIIR) were used to determine the role of endogenous TGF-betas in the developing mammary gland. The expression of the dominant-negative receptor was induced with zinc and was primarily localized to the stroma underlying the ductal epithelium in the mammary glands of virgin transgenic mice from two separate mouse lines. In MT-DNIIR virgin females treated with zinc, there was an increase in lateral branching of the ductal epithelium. We tested the hypothesis that expression of the dominant-negative receptor may alter expression of genes that are expressed in the stroma and regulated by TGF-betas, potentially resulting in the increased lateral branching seen in the MT-DNIIR mammary glands. The expression of hepatocyte growth factor mRNA was increased in mammary glands from transgenic animals relative to the wild-type controls, suggesting that this factor may play a role in TGF-beta-mediated regulation of lateral branching. Loss of responsiveness to TGF-betas in the mammary stroma resulted in increased branching in mammary epithelium, suggesting that TGF-betas play an important role in the stromal-epithelial interactions required for branching morphogenesis.

Indexed as

Protein Serine-Threonine KinasesAnimalsCells, CulturedEstrusFemaleFibroblastsMammary Glands, AnimalMetallothioneinMiceMice, TransgenicPolymerase Chain ReactionPromoter Regions, GeneticReceptor Protein-Tyrosine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IReceptor, Transforming Growth Factor-beta Type IIMetallothioneinProtein Serine-Threonine KinasesReceptor Protein-Tyrosine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IReceptor, Transforming Growth Factor-beta Type IIRecombinant Fusion Proteins

Identifiers

PMID10198068
PMCPMC25256
OpenAlexW2128739635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.